serlopitant

A pair of PhIII failures spells last rites for Menlo’s once-promising Merck drug
Endpoints
Mon, 04/6/20 - 10:33 am
Menlo Therapeutics
clinical trials
serlopitant
Upcoming events – Filgotinib's ulcerative colitis data and serlopitant takes on pruritus
EP Vantage
Fri, 02/21/20 - 10:35 am
Gilead Sciences
Galapagos
filgotinib
ulcerative colitis
Menlo Therapeutics
serlopitant
Peninsula biotech coughs up 40 percent of its value on failed clinical trial
Bizjournals.com
Mon, 10/8/18 - 10:53 pm
clinical trials
IPOs
Menlo Therapeutics
serlopitant